Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iheezo vs Lidocaine for Intravitreal Injection Pain
NCT07895420Phase 4Recruiting
- Sponsor
- Retina Research Institute
- Start
- Oct 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 4, randomised trial of chloroprocaine in pain (2 arms), sponsored by Retina Research Institute. Primary endpoint: Pain Scores at 4 hours. Started Oct 2025; status: recruiting.
02
Drugs
chloroprocaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT07895420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07895420.